Who We Are
By supporting the brain’s ability to repair itself while keeping a sharp focus on unique, noninvasive platform technologies, we are dedicated to developing and expanding treatment options to increase patients’ independence and overall quality of life.
The History of Helius
( How We Got Here )
PoNS Therapy™ receives authorization in Canada for the treatment of balance deficit due to mmTBI
PoNS™ becomes available commercially, for the first time, to patients in Canada for the treatment of balance deficit due to mmTBI
Helius Medical receives FDA Breakthrough Designation for PoNS treatment of gait deficit due to symptoms of MS
Helius Medical submitted request for FDA de novo classification
PoNS Therapy receives authorization in Canada for the treatment of gait deficit due to mild and moderate symptoms of MS
Helius Medical receives US marketing authorization for the PoNS® device
PoNS® becomes available commercially by prescription, for the first time, to patients in the U.S. for the treatment of gait deficit due to MS
Helius Medical launches online PoNS Therapy training for rehabilitation specialists
Get to know the hearts and minds of the driven individuals that lead Helius Medical. With countless years of combined experience, our team of leaders not only steers the company in the right direction, but toward the goal of changing the standard of care in neuromodulation technology.